The American Society of Clinical Oncology-College of American Pathologists Guideline Update for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

被引：7
|
作者：
Schnitt, Stuart J. [1 ,2 ,6 ]
Tarantino, Paolo [3 ,4 ]
Collins, Laura C. [2 ,5 ]
机构：
[1] Brigham & Womens Hosp, Dept Pathol, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA USA
[4] Univ Milan, Dept Oncol & Hemato Oncol, Milan, Italy
[5] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA USA
[6] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 2023年 / 147卷 / 09期
关键词：
RECOMMENDATIONS;
D O I：
10.5858/arpa.2023-0187-ED
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：991 / 992
页数：2
相关论文
共 50 条
  • [31] Human Epidermal Growth Factor Receptor 2 Testing by Fluorescent In Situ Hybridization: Positive or Negative? American Society of Clinical Oncology/College of American Pathologists Guidelines 2007, 2013, and 2018
    Murray, Ciara
    D'Arcy, Clare
    Gullo, Giuseppe
    Flanagan, Louise
    Quinn, Cecily M.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2019, 143 (04) : 412 - 413
  • [32] Laboratory Compliance With the American Society of Clinical Oncology/College of American Pathologists Human Epidermal Growth Factor Receptor 2 Testing Guidelines A 3-Year Comparison of Validation Procedures
    Dyhdalo, Kathryn S.
    Fitzgibbons, Patrick L.
    Goldsmith, Jeffery D.
    Souers, Rhona J.
    Nakhleh, Raouf E.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2014, 138 (07) : 876 - 884
  • [33] Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer
    Shah, Sejal S.
    Ketterling, Rhett P.
    Goetz, Matthew P.
    Ingle, James N.
    Reynolds, Carol A.
    Perez, Edith A.
    Chen, Beiyun
    HUMAN PATHOLOGY, 2010, 41 (01) : 103 - 106
  • [34] National Guidelines and Level of Evidence: Comments on Some of the New Recommendations in the American Society of Clinical Oncology and the College of American Pathologists Human Epidermal Growth Factor Receptor 2 Guidelines for Breast Cancer Reply
    Wolff, Antonio C.
    Hammond, M. Elizabeth H.
    Hicks, David G.
    Allison, Kimberly H.
    Bartlett, John M. S.
    Bilous, Michael
    Fitzgibbons, Patrick
    Hanna, Wedad
    Jenkins, Robert B.
    Mangu, Pamela B.
    Paik, Soonmyung
    Perez, Edith A.
    Press, Michael F.
    Spears, Patricia A.
    Vance, Gail H.
    Viale, Giuseppe
    Dowsett, Mitch
    McShane, Lisa M.
    Hayes, Daniel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (11) : 1302 - 1304
  • [35] Comparative analysis of human epidermal growth factor receptor 2 (HER2) testing in breast cancer according to 2007 and 2013 American Society of Clinical Oncology / College of American Pathologist guideline recommendations (ASCO/CAP)
    Wernicke, A.
    De la Iglesia, P.
    Garcia Rivello, H.
    VIRCHOWS ARCHIV, 2018, 473 : S31 - S31
  • [36] Impact of 2018 American Society of Clinical Oncology/College of American Pathologists Clinical Guidelines Update on HER-2 Oncogene Testing in Breast Cancer Cases
    Guadalupe, Lorena Di Pasquale
    Khazai, Laila
    Xiong, Yin
    Agosto-Arroyo, Emmanuel
    MODERN PATHOLOGY, 2019, 32
  • [37] Impact of 2018 American Society of Clinical Oncology/College of American Pathologists Clinical Guidelines Update on HER-2 Oncogene Testing in Breast Cancer Cases
    Guadalupe, Lorena Di Pasquale
    Khazai, Laila
    Xiong, Yin
    Agosto-Arroyo, Emmanuel
    LABORATORY INVESTIGATION, 2019, 99
  • [38] American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)
    Hammond, M. Elizabeth H.
    Hayes, Daniel F.
    Dowsett, Mitch
    Allred, D. Craig
    Hagerty, Karen L.
    Badve, Sunil
    Fitzgibbons, Patrick L.
    Francis, Glenn
    Goldstein, Neil S.
    Hayes, Malcolm
    Hicks, David G.
    Lester, Susan
    Love, Richard
    Mangu, Pamela B.
    McShane, Lisa
    Miller, Keith
    Osborne, C. Kent
    Paik, Soonmyung
    Perlmutter, Jane
    Rhodes, Anthony
    Sasano, Hironobu
    Schwartz, Jared N.
    Sweep, Fred C. G.
    Taube, Sheila
    Torlakovic, Emina Emilia
    Valenstein, Paul
    Viale, Giuseppe
    Visscher, Daniel
    Wheeler, Thomas
    Williams, R. Bruce
    Wittliff, James L.
    Wolff, Antonio C.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2010, 134 (07) : E48 - E72
  • [39] Human Epidermal Growth Factor Receptor 2 Testing by Fluorescent In Situ Hybridization: Positive or Negative? American Society of Clinical Oncology/College of American Pathologists Guidelines 2007, 2013, and 2018 Reply
    Wolff, Antonio C.
    Hammond, M. Elizabeth Hale
    Allison, Kimberly H.
    Harvey, Brittany E.
    McShane, Lisa M.
    Dowsett, Mitchell
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2019, 143 (04) : 413 - 414
  • [40] Impact of 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) Guideline Recommendations on Human Epidermal Growth Factor Receptor 2 (HER2) Fluorescent In-Situ Hybridization (FISH) Testing in Breast Cancer - Retrospective Study of 709 Cases
    Singh, Kamaljeet
    Tantravahi, Umadevi
    Steinhoff, Margaret
    Lomme, Michele
    Pasquariello, Terese
    Sung, C. James
    MODERN PATHOLOGY, 2015, 28 : 67A - 67A
12345